Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis (Q44293608)

1 December 2017

title

Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis (English)

1 reference

1 December 2017

1 reference

acute coronary syndrome

1 reference

2

1 reference

Solbritt Rantapää Dahlqvist

1 December 2017

series ordinal

4

1 reference

1 December 2017

Lotta Ljung

1

0 references

Lennart T. H. Jacobsson

series ordinal

3

object named as

Lennart Jacobsson

1 reference

1 December 2017

Johan Askling

5

1 reference

1 December 2017

Anti-Rheumatic Therapy in Sweden (ARTIS) Study Group

series ordinal

6

1 reference

1 December 2017

publication date

1 January 2012

1 reference

1 December 2017

published in

Arthritis & Rheumatology

1 reference

1 December 2017

volume

64

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

42-52

1 reference

Preclinical carotid atherosclerosis in patients with rheumatoid arthritis

1 December 2017

cites work

1 reference

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis

21 January 2018

1 reference

Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study

21 January 2018

1 reference

High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study

21 January 2018

1 reference

The mortality of rheumatoid arthritis

21 January 2018

1 reference

Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation

21 January 2018

1 reference

Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006.

21 January 2018

1 reference

Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.

21 January 2018

1 reference

No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish population-based rheumatoid arthritis cohorts.

21 January 2018

1 reference

Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis

21 January 2018

1 reference

Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis

21 January 2018

1 reference

Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients

21 January 2018

1 reference

What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology.

21 January 2018

1 reference

Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis

21 January 2018

1 reference

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register

21 January 2018

1 reference

The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis

21 January 2018

1 reference

All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists

21 January 2018

1 reference

Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis.

21 January 2018

1 reference

Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study

21 January 2018

1 reference

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

21 January 2018

1 reference

Measurement of patient outcome in arthritis

21 January 2018

1 reference

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register

21 January 2018

1 reference

Swedish registers to examine drug safety and clinical issues in RA.

21 January 2018

1 reference

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

21 January 2018

1 reference

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis

21 January 2018

1 reference

Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis.

21 January 2018

1 reference

Tumor necrosis factor-alpha and its receptors 1 and 2: Yin and Yang in myocardial infarction?

21 January 2018

1 reference

Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study

21 January 2018

1 reference

Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging

21 January 2018

1 reference

Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: Observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatolog

21 January 2018

1 reference

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

21 January 2018

1 reference

Which factors are related to the presence of atherosclerosis in rheumatoid arthritis?

21 January 2018

1 reference

Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study

21 January 2018

1 reference

Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction

21 January 2018

1 reference

Effect of anti–tumor necrosis factor α therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis

21 January 2018

1 reference

Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long‐term infliximab therapy

21 January 2018

1 reference

Targeted Overexpression of Noncleavable and Secreted Forms of Tumor Necrosis Factor Provokes Disparate Cardiac Phenotypes

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.30654

1 reference

1 December 2017

1 reference